Home › Funds › Palo Alto Investors LP › AGIO

Palo Alto Investors LP position in AGIO

AGIOS PHARMACEUTICALS INC · Health Care

Palo Alto Investors LP reported holding 200,984 shares of AGIO (AGIOS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 0.99% of its reported portfolio and ranking #24 among its reported holdings. Palo Alto Investors LP has disclosed AGIO holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)200.98K sh
Reported value held$6.68M
Portfolio Weight0.99%
First reportedQ1 2025
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's AGIO position evolved

Palo Alto Investors LP first disclosed a stake in AGIO in Q1 2025 at 276,578 shares (US$8.1M). The position peaked in Q3 2025 at 265,497 shares, worth US$10.7M. Across 7 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 200,984 shares valued at US$6.7M — a reduction of -12,617 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 276.58K $8.10M New
Q2 2025 268.78K $8.94M Reduce
Q3 2025 265.50K $10.66M Reduce
Q4 2025 212.50K $5.78M Reduce
Q1 2026 213.60K $7.23M Add
Q2 2026 213.60K $7.93M Hold
Q3 2026 200.98K $6.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGIO and 13F data

AGIO (AGIOS PHARMACEUTICALS INC) is a Health Care company. 27 other funds we track also report a position in AGIO — the largest reported positions include Farallon Capital Management (US$219.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$197.5M), ARMISTICE CAPITAL, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGIO

All AGIO fund holders →

FAQ

How long has Palo Alto Investors LP held AGIO?

Palo Alto Investors LP has disclosed AGIO holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Palo Alto Investors LP's current position in AGIO?

As of Q3 2026, Palo Alto Investors LP holds 200.98K shares of AGIO (AGIOS PHARMACEUTICALS INC), valued at $6.68M, representing 0.99% of its reported portfolio and ranking #24.

Has Palo Alto Investors LP been buying or selling AGIO?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in AGIO. The position peaked in Q3 2025 at 265.50K shares.

Which other funds hold AGIO?

Other major institutional holders of AGIO include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARMISTICE CAPITAL, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.